Navigation Links
Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
Date:4/13/2009

Chestnut Hill, Mass. (April 13, 2009) Boston College Chemistry Professor Udayan Mohanty has been awarded a 2009 John Simon Guggenheim Memorial Foundation Fellowship for his theoretical studies of rare chemical reactions.

Mohanty said he was honored to be among the 180 scientists, artists and scholars chosen from a field of 3,000 applicants. The only U.S. chemist to receive a Guggenheim this year, Mohanty credited his Boston College colleagues for their support of his interdisciplinary research.

"When you work on these kinds of problems that take years of work, it is important to be surrounded by people who provide you with inspiration both new faculty who bring energy and excitement and senior faculty who are intellectually world class," said Mohanty, who has been at Boston College since 1985.

Trained as a physical chemist, Mohanty embarked on an interdisciplinary research program in 1997 across the fields of modern physical chemistry, biophysics, biophysical chemistry and soft condensed matter physics.

Mohanty said his fellowship will allow him to spend the next year using new computational models to develop a set of tools that will allow scientists to describe rare fluctuations in chemical systems. He hopes to discover chemical reaction pathways that are as yet unknown, in particular those surrounding the behavior of DNA and RNA.

Mohanty joins a distinguished list of fellow BC chemists who have previously received Guggenheim Fellowships, including John Tully, Margaret Tolbert, and Laura Kiessling.


'/>"/>

Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert

Page: 1

Related biology news :

1. Boston University biomedical engineers find chink in bacterias armor
2. Boston College profs study oxidative stress subcellular to discover its role in diseases
3. DHS Begins Collecting 10 Fingerprints From International Visitors at Boston Logan International Airport
4. Singapores BIOPOLIS and FUSIONOPOLIS on stage in Boston this week
5. Software developed by Boston College lab delivers speed and accuracy to genome research
6. At Boston symposium, NARSAD researchers report on genes and family traits
7. American College of Medical Genetics responds to new FDA labeling decision for warfarin
8. Study finds a high rate of asthma in college athletes
9. University of Minnesota releases first ever comprehensive report of the health of college students
10. 2 federal public health grants awarded to Weill Cornell Medical College
11. KAUST announces academic excellence alliance partnership with Imperial College London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... , March 21, 2017 Vigilant Solutions ... serving law enforcement agencies, announced today the appointment of ... director of public safety business development. Mr. ... enforcement experience, including a focus on the aviation transportation ... most recent position, Mr. Sheridan served as the Aviation ...
(Date:3/13/2017)... HAMBURG, Germany , March 13, 2017 Future of ... ... DERMALOGs Face Matching enables to match ... characteristics forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... year,s petition to the White House signed by 120,000 ... generate awareness on the importance of new organic medicines and nutritional ... place. ... this month Health Advance (OTC PINK: HADV ), ... announced its endeavors on this generally recognized as safe ...
(Date:3/29/2017)... ... March 29, 2017 , ... (March 29, 2017) — ... approved as an active member of the Mexican Direct Selling Association A.C. ... consumers in relationship marketing. This professional organization fosters loyal and fair competition among ...
(Date:3/29/2017)... March 29, 2017  Halozyme Therapeutics, Inc. (NASDAQ: ... drug-delivery therapies, today announced that an Oncologic Drug ... Administration voted 11 to 0 that the benefit/risk ... was favorable for patients in the proposed indications ... chronic lymphocytic leukemia. The FDA action date is ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... it is exhibiting in booth 513 at the Association of Community Cancer Centers ... Hotel, March 29-31. , CANCERSCAPE unites key stakeholders from leading national organizations ...
Breaking Biology Technology: